Industry

Focus on joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases Current efforts focused on treatment options for specific forms of cardiovascular disease such as dilated cardiomyopathy Phase I clinical study in healthy volunteers for development of new treatment for patients with atrial fibrillation recently initiated Extended … [Read more…]

HUNT VALLEY, Md.–(BUSINESS WIRE)–Omega Healthcare Investors, Inc. (NYSE: OHI) (“Omega”) today announced that it priced an underwritten public offering of $600,000,000 aggregate principal amount of 5.200% Senior Notes due 2030 (the “2030 Notes”). The settlement of this offering is expected to occur on June 20, 2025, subject to customary closing conditions. Omega intends to use … [Read more…]

HHS Interrupts “The Most Cost-Beneficial Intervention In Healthcare” UPPER NYACK, N.Y.–(BUSINESS WIRE)–Yesterday, the Secretary of Health and Human Services (HHS) removed all sitting members of the Advisory Committee on Immunization Practices (ACIP), the expert panel that advises the Centers for Disease Control and Prevention (CDC) on vaccine use. While the groups such as the Global … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Preimplantation Genetic Testing Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F” has been added to ResearchAndMarkets.com’s offering. The Preimplantation Genetic Testing Market was valued at USD 0.66 Billion in 2024 and is expected to reach USD 1.05 Billion by 2030, rising at a CAGR of 8.20%. Preimplantation Genetic Testing (PGT) … [Read more…]

Appointment strengthens leadership team to drive strategy focused on harnessing 3D multi-omics to identify high-confidence, high-value therapeutic targets, to accelerate drug discovery CAMBRIDGE, England–(BUSINESS WIRE)–Enhanced Genomics (‘Enhanced’ or ‘the Company’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced the appointment of Dietrich Stephan, Ph.D. … [Read more…]

BOCA RATON, Fla.–(BUSINESS WIRE)–#AndrewQueen—Integrated Dermatology, the country’s largest independent dermatology provider, is pleased to welcome Amanda Derwae, MD, FAAD, to the team of expert dermatologists at Integrated Dermatology of Fairfax in Virginia. Dr. Derwae, who is now accepting new patients, is a board-certified dermatologist with an impressive career spanning both military and civilian medicine. Dr. … [Read more…]

Built-in incubation, automated imaging, and AI-ready data generation deliver in vivo fidelity at scale BOSTON–(BUSINESS WIRE)–Emulate, Inc., the world leader in Organ-on-a-Chip technology, today announced the commercial launch of the AVA™ Emulation System, a self-contained instrument that cultures, incubates, and images up to 96 independent Organ-Chip samples in a single run. AVA delivers an unprecedented … [Read more…]

First global filing for potentially best-in-class TGCT treatment based on strong positive data from Phase 3 MANEUVER study Potential for pimicotinib to be first systemic TGCT therapy approved in China, following recent granting of Priority Review by CDE Additional applications planned in the US and other markets around the world  Not intended for Canada-, UK- … [Read more…]

BOSTON & SYDNEY–(BUSINESS WIRE)–Berkshire Hathaway Specialty Insurance (BHSI) today announced the introduction of a Management Liability Insurance Policy tailored expressly for Life Science, BioTech and Pharmaceutical (LBP) companies in Australia. “The new LBP Management Liability Policy reflects our commitment to Australia’s thriving life sciences community and our deep understanding of the challenges start-ups face at … [Read more…]

QUÉBEC CITY–(BUSINESS WIRE)–Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to inflammatory diseases, today announced the appointment of Dr. André Boulet as Chief Executive Officer of the Corporation, replacing Mr. Luc Gregoire who will continue in the new role of Executive Vice-President … [Read more…]